Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xuanfeizhisuheji for acute bronchitis and post-infectious cough
ChiCTR2100053411Phase 4Completed
- Sponsor
- China-Japan Friendship Hospital
- Start
- Sep 2021
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of xuanfeizhisuheji in acute bronchitis and postinfectious cough (2 arms), sponsored by China-Japan Friendship Hospital. Primary endpoints: Time of cough relief, Time of cough disappearance and 8 more. Started Sep 2021; status: completed.
02
Drugs
xuanfeizhisuheji
03
Conditions
acute bronchitispostinfectious cough
Beyond the preview
Go deeper on ChiCTR2100053411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053411.